Skip to main content
Top

04-05-2024 | Heart Failure | Review

Impact of Sex in the Incidence of Heart Failure in Patients with Chronic Coronary Syndrome

Authors: Ramón López-Palop, Pilar Carrillo, Íñigo Lozano

Published in: Current Heart Failure Reports

Login to get access

Abstract

Purpose of Review

This review examines the available evidence concerning the incidence of heart failure in patients with chronic coronary syndrome, with a focus on gender differences.

Recent Findings

The incidence of heart failure in the context of chronic coronary syndrome presents conflicting data. Most of the available information stems from studies involving stable patients’ post-acute coronary syndrome, revealing a wide range of incidence rates, from less than 3% to over 20%, observed over 5 years of follow-up. Regarding the gender differences in heart failure incidence, there is no consensus about whether women exhibit a higher incidence, particularly in the presence of evidence of obstructive coronary artery disease. However, in cases where obstructive coronary artery disease is absent, women may face a more unfavourable prognosis due to a higher prevalence of microvascular disease and heart failure with preserved ventricular function.

Summary

The different profile of ischaemic heart disease in women difficult to establish differences in prognosis independently associated with female sex. Targeted investigations are essential to discern the incidence of heart failure in chronic coronary syndrome and explore potential gender-specific associations.
Literature
2.
go back to reference Virani SS, Newby LK, Arnold SV, Bittner V, Brewer LC, Demeter SH, et al. 2023 AHA/ACC/ACCP/ASPC/NLA/PCNA Guideline for the Management of Patients With Chronic Coronary Disease: A Report of the American Heart Association/American College of Cardiology Joint Committee on Clinical Practice Guidelines. J Am Coll Cardiol. 2023;82(9):833–955. https://doi.org/10.1016/j.jacc.2023.04.003.CrossRefPubMed Virani SS, Newby LK, Arnold SV, Bittner V, Brewer LC, Demeter SH, et al. 2023 AHA/ACC/ACCP/ASPC/NLA/PCNA Guideline for the Management of Patients With Chronic Coronary Disease: A Report of the American Heart Association/American College of Cardiology Joint Committee on Clinical Practice Guidelines. J Am Coll Cardiol. 2023;82(9):833–955. https://​doi.​org/​10.​1016/​j.​jacc.​2023.​04.​003.CrossRefPubMed
6.
go back to reference McDonagh TA, Metra M, Adamo M, Gardner RS, Baumbach A, Böhm M, et al. 2021 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure: Developed by the Task Force for the diagnosis and treatment of acute and chronic heart failure of the European Society of Cardiology (ESC) With the special contribution of the Heart Failure Association (HFA) of the ESC. Eur Heart J. 2021;42(36):3599–726. https://doi.org/10.1093/eurheartj/ehab368.CrossRefPubMed McDonagh TA, Metra M, Adamo M, Gardner RS, Baumbach A, Böhm M, et al. 2021 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure: Developed by the Task Force for the diagnosis and treatment of acute and chronic heart failure of the European Society of Cardiology (ESC) With the special contribution of the Heart Failure Association (HFA) of the ESC. Eur Heart J. 2021;42(36):3599–726. https://​doi.​org/​10.​1093/​eurheartj/​ehab368.CrossRefPubMed
14.
19.
go back to reference Boden WE, O’Rourke RA, Teo KK, Hartigan PM, Maron DJ, Kostuk WJ, et al. Optimal medical therapy with or without PCI for stable coronary disease. N Engl J Med. 2007;356(15):1503–16.CrossRefPubMed Boden WE, O’Rourke RA, Teo KK, Hartigan PM, Maron DJ, Kostuk WJ, et al. Optimal medical therapy with or without PCI for stable coronary disease. N Engl J Med. 2007;356(15):1503–16.CrossRefPubMed
22.
go back to reference • Acharjee S, Teo KK, Jacobs AK, Hartigan PM, Barn K, Gosselin G, et al. Optimal medical therapy with or without percutaneous coronary intervention in women with stable coronary disease: A pre-specified subset analysis of the Clinical Outcomes Utilizing Revascularization and Aggressive druG Evaluation (COURAGE) trial. Am Heart J. 2016;173:108-17. https://doi.org/10.1016/j.ahj.2015.07.020. Sub-study of the COURAGE clinical trial revealing a poorer prognosis solely in women managed conservatively. Results suggest potential benefits of percutaneous revascularization in women with stable coronary artery disease. • Acharjee S, Teo KK, Jacobs AK, Hartigan PM, Barn K, Gosselin G, et al. Optimal medical therapy with or without percutaneous coronary intervention in women with stable coronary disease: A pre-specified subset analysis of the Clinical Outcomes Utilizing Revascularization and Aggressive druG Evaluation (COURAGE) trial. Am Heart J. 2016;173:108-17. https://​doi.​org/​10.​1016/​j.​ahj.​2015.​07.​020. Sub-study of the COURAGE clinical trial revealing a poorer prognosis solely in women managed conservatively. Results suggest potential benefits of percutaneous revascularization in women with stable coronary artery disease.
23.
go back to reference Oliveira Guimaraes P, Granger CB, Stebbins A, Chiswell K, Held C, Hochman JS, et al. Sex Differences in Clinical Characteristics, Psychosocial Factors, and Outcomes Among Patients With Stable Coronary Heart Disease: Insights from the STABILITY (Stabilization of Atherosclerotic Plaque by Initiation of Darapladib Therapy) Trial. J Am Heart Assoc. 2017;6(9). https://doi.org/10.1161/JAHA.117.006695 Oliveira Guimaraes P, Granger CB, Stebbins A, Chiswell K, Held C, Hochman JS, et al. Sex Differences in Clinical Characteristics, Psychosocial Factors, and Outcomes Among Patients With Stable Coronary Heart Disease: Insights from the STABILITY (Stabilization of Atherosclerotic Plaque by Initiation of Darapladib Therapy) Trial. J Am Heart Assoc. 2017;6(9). https://​doi.​org/​10.​1161/​JAHA.​117.​006695
28.
go back to reference Lawless M, Appelman Y, Beltrame JF, Navarese EP, Ratcovich H, Wilkinson C, Kunadian V. Sex differences in treatment and outcomes amongst myocardial infarction patients presenting with and without obstructive coronary arteries: a prospective multicentre study Eur Heart J Open. 2023; 3(2):oead033. https://doi.org/10.1093/ehjopen/oead033 Lawless M, Appelman Y, Beltrame JF, Navarese EP, Ratcovich H, Wilkinson C, Kunadian V. Sex differences in treatment and outcomes amongst myocardial infarction patients presenting with and without obstructive coronary arteries: a prospective multicentre study Eur Heart J Open. 2023; 3(2):oead033. https://​doi.​org/​10.​1093/​ehjopen/​oead033
31.
go back to reference •• Elia E, Bruno F, Crimi G, Wanha W, Leonardi S, Mauro M, et al. Gender differences in the development of heart failure after acute coronary syndrome: Insight from the CORALYS registry. Int J Cardiol. 2024;397: 131622. https://doi.org/10.1016/j.ijcard.2023.131622. Study involving a substantial cohort of patients managed according to contemporary criteria, comparing outcomes between genders. Notable conclusions highlight equivalent long-term mortality despite variances in other events (including congestive heart failure).CrossRefPubMed •• Elia E, Bruno F, Crimi G, Wanha W, Leonardi S, Mauro M, et al. Gender differences in the development of heart failure after acute coronary syndrome: Insight from the CORALYS registry. Int J Cardiol. 2024;397: 131622. https://​doi.​org/​10.​1016/​j.​ijcard.​2023.​131622. Study involving a substantial cohort of patients managed according to contemporary criteria, comparing outcomes between genders. Notable conclusions highlight equivalent long-term mortality despite variances in other events (including congestive heart failure).CrossRefPubMed
36.
go back to reference •• Gulati M, Cooper-DeHoff RM, McClure C, Johnson BD, Shaw LJ, Handberg EM, et al. Adverse cardiovascular outcomes in women with nonobstructive coronary artery disease: a report from the Women’s Ischemia Syndrome Evaluation Study and the St James Women Take Heart Project. Arch Intern Med. 2009;169(9):843–850. https://doi.org/10.1001/archinternmed.2009.50. Significant as the most extensive series demonstrating the adverse prognosis of ischemia with non-obstructive coronary artery disease (INOCA) in women compared to a control group of healthy females.CrossRefPubMedPubMedCentral •• Gulati M, Cooper-DeHoff RM, McClure C, Johnson BD, Shaw LJ, Handberg EM, et al. Adverse cardiovascular outcomes in women with nonobstructive coronary artery disease: a report from the Women’s Ischemia Syndrome Evaluation Study and the St James Women Take Heart Project. Arch Intern Med. 2009;169(9):843–850. https://​doi.​org/​10.​1001/​archinternmed.​2009.​50. Significant as the most extensive series demonstrating the adverse prognosis of ischemia with non-obstructive coronary artery disease (INOCA) in women compared to a control group of healthy females.CrossRefPubMedPubMedCentral
37.
46.
go back to reference Eisen A, Bhatt DL, Steg PG, Eagle KA, Goto S, Guo J, et al. Angina and Future Cardiovascular Events in Stable Patients With Coronary Artery Disease: Insights From the Reduction of Atherothrombosis for Continued Health (REACH) Registry. J Am Heart Assoc. 2016;5(10). https://doi.org/10.1161/JAHA.116.004080. Eisen A, Bhatt DL, Steg PG, Eagle KA, Goto S, Guo J, et al. Angina and Future Cardiovascular Events in Stable Patients With Coronary Artery Disease: Insights From the Reduction of Atherothrombosis for Continued Health (REACH) Registry. J Am Heart Assoc. 2016;5(10). https://​doi.​org/​10.​1161/​JAHA.​116.​004080.
50.
go back to reference Lewis EF, Velazquez EJ, Solomon SD, Hellkamp AS, McMurray JJ, Mathias J, et al. Predictors of the first heart failure hospitalization in patients who are stable survivors of myocardial infarction complicated by pulmonary congestion and/or left ventricular dysfunction: a VALIANT study. Eur Heart J. 2008;29(6):748–56. https://doi.org/10.1093/eurheartj/ehn062.CrossRefPubMed Lewis EF, Velazquez EJ, Solomon SD, Hellkamp AS, McMurray JJ, Mathias J, et al. Predictors of the first heart failure hospitalization in patients who are stable survivors of myocardial infarction complicated by pulmonary congestion and/or left ventricular dysfunction: a VALIANT study. Eur Heart J. 2008;29(6):748–56. https://​doi.​org/​10.​1093/​eurheartj/​ehn062.CrossRefPubMed
59.
91.
go back to reference Michel TC, Abhiram P, Rajiv G, Lilach OL, Amir L. Sex-specific differences in coronary blood flow and flow velocity reserve in symptomatic patients with non-obstructive disease. EuroIntervention. 2021;16(13):1079–84.CrossRef Michel TC, Abhiram P, Rajiv G, Lilach OL, Amir L. Sex-specific differences in coronary blood flow and flow velocity reserve in symptomatic patients with non-obstructive disease. EuroIntervention. 2021;16(13):1079–84.CrossRef
Metadata
Title
Impact of Sex in the Incidence of Heart Failure in Patients with Chronic Coronary Syndrome
Authors
Ramón López-Palop
Pilar Carrillo
Íñigo Lozano
Publication date
04-05-2024
Publisher
Springer US
Published in
Current Heart Failure Reports
Print ISSN: 1546-9530
Electronic ISSN: 1546-9549
DOI
https://doi.org/10.1007/s11897-024-00663-z
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine
Webinar | 06-02-2024 | 20:00 (CET)

Mastering chronic pancreatitis pain: A multidisciplinary approach and practical solutions

Severe pain is the most common symptom of chronic pancreatitis. In this webinar, experts share the latest insights in pain management for chronic pancreatitis patients. Experts from a range of disciplines discuss pertinent cases and provide practical suggestions for use within clinical practice.

Sponsored by: Viatris

Developed by: Springer Healthcare